Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
Primary Industries
- Diagnostic
- Cancer
- Drugs
- Biotechnology
- Disease
- Diagnostic Substances
- Medical
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 28082
License Grant
The Licensee and Licensor desire to collaborate in the development of products in the aforementioned areas utilizing their respective technologies and expertise, with the intent that such new products shall be developed and manufactured, in part by each, and marketed and sold for in vitro diagnostic applications exclusively by the Licensee in the United States and Canada and their respective territories and possessions.
License Property
The Licensor has expertise and certain proprietary technology relating to cell enrichment, isolation and analysis systems, including fluorescence assay instrumentation, reagents and assays for the isolation and detection and diagnosis of certain disease states of mammalian and other cells or cellular components in tissue, blood or other body fluids, and Immunicon has intellectual property including certain patents and know-how pertaining to such proprietary technology.
Field of Use
Field means the in vitro application of Instrument Systems for the diagnosis or monitoring of Target Entities for the Infectious Diseases in humans solely by detection of or and/or utilizing Products. For the resolution of doubt but not in limitation, the Field shall not include conditions; applications or analysis involving circulating in blood, for analysis of taken by for assessing applications involving techniques; or applications involving techniques.
IPSCIO Record ID: 249756
License Grant
Licensor grants a world-wide exclusive right under Licensor Inventions to make, have made, use, sell, and have sold Cellular Analysis Products and Automated Cell Analysis Systems within the Field subject to the limitations set forth elsewhere in this Agreement. License shall have the right to sublicense. For the resolution of doubt, the grant of this license shall have no effect on Licensors rights outside the Field.
Licensor grants a world-wide sole right to reproduce, prepare derivative works, distribute, perform, and display Licensor Works in the Field.
License Property
The patents and inventions relate to products for the enrichment or isolation of one more intact cells from body fluids and related instrumentation, whether owned as of the date hereof or hereafter acquired or licensed pursuant to the Development Program.
Field of Use
Field means the human in vitro application of Cellular Diagnostics to Cancer and PreCancerous conditions. For the resolution of doubt, the Field shall not include cardiovascular diagnostics and screening, neurological disorder diagnostics, infectious disease diagnostics, hematology, standard blood serum immunoassays for soluble, markers and analysis of cells taken by tissue biopsy.
IPSCIO Record ID: 28895
License Grant
The Licensor and the Licensee will collaborate to produce products based upon their respective technologies and businesses with the intent that a full range of cellular human cancer diagnostics and marketed and distributed worldwide.
License Property
The Licensor has certain patents and know-how relating to assays useful in the detection of certain human cellular conditions such as the presence of cancerous or pre-cancerous cells in peripheral blood or other body fluids.
Field of Use
Field means the human in vitro application of Cellular Diagnostics to Cancer and Pre-Cancerous conditions.
The Parties desire to collaborate to produce products based upon their respective technologies and businesses with the intent that a full range of cellular human cancer diagnostics shall be developed and manufactured, in part, by the Licensor and manufactured in part by the Licensee, and marketed and distributed worldwide by the Licensee.
IPSCIO Record ID: 25803
License Grant
The University grants an exclusive license under the patents and technology to use, have used, manufacture, have manufactured, sell and/or have sold licensed products within the licensed territory and licensed field.
License Property
The licensed patents and technology are for methods and reagents for detecting and characterizing carcinoma cells in the blood.
The technology licensed relates to the isolation, enrichment and characterization of circulating epithelial cells. Epithelial cells are cells that cover external and internal body surfaces and give rise to the majority of solid tumors. This technology and the underlying patents and know-how contribute significantly to the Licensee's cell analysis products in the field of cancer diagnostics.
1. U.S. Provisional Patent Application Serial Number 60/074,535, filed February 12, 1998, entitled 'Test For Detecting, Enumerating and Characterizing Carcinoma Cells in the Blood' (corresponding for reference purposes only to UT SOUTHWESTERN file number UTSD568-PZ1).
2. U.S. Provisional Patent Application Serial Number 60/110,202, filed November 30, 1998, entitled 'Detection and Characterization of Carcinoma Cells in the Blood' (corresponding for reference purposes only to UT SOUTHWESTERN file number UTSD568-PZ2).
3. U.S. Patent Application Serial Number 09/248,388, filed February 12, 1999, entitled 'Methods and Reagents for the Rapid and Efficient Isolation of Circulating Cancer Cells' (corresponding for reference purposes only to UT SOUTHWESTERN file number UTSD568).
Field of Use
The Licensed Field means isolation, enrichment and characterization of circulating epithelial cells, and determination of their relationship to cancer disease states.
IPSCIO Record ID: 26464
License Grant
The Licensee was granted the non-exclusive right to polymerase chain reaction technology or 'PCR' to perform the Licensed Services within the United States and its possessions and the Commonwealth of Puerto Rico.
The Licensed Services shall mean the performance of an Assay by BTRL to detect nucleic acid sequences associated with a human disease or condition within the Licensed Field. Licensed Services include but are not limited to, any combination of the steps of collecting a sample for analysis, isolating nucleic acid sequences therein, amplifying one or more desired sequences, analyzing the amplified material and reporting the results.
License Property
PCR Technology shall mean polymerase chain reaction technology covered by United States Patent Nos. B1 4,683,195 and B1 4,683,202.
Field of Use
The Licensed Field shall mean the field of human in vitro diagnostics solely for the detection of genetic diseases, genetic pre-disposition to disease, microorganisms associated with infectious diseases, cancer, or for tissue transplant typing or Parentage.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
